Proton beam therapy indications in the Kingdom of Saudi Arabia
The Panel did not recommend the routine use of proton therapy for all cancers. Each case should be assessed individually following a multidisciplinary review and expert consultation while accounting for financial, logistical, and patient-specific factors.
Authors
- Abdulaziz S. Alghamdi (ORCID: https://orcid.org/0000-0002-1274-6454)
- Maha Othman (ORCID: https://orcid.org/0000-0001-7562-203X)
- Yasir A. Bahadur (ORCID: https://orcid.org/0000-0002-7434-9921)
- Majed Alghamdi (ORCID: https://orcid.org/0000-0003-0779-079X)
- Yasir Alayed (ORCID: https://orcid.org/0000-0002-4315-0485)
- Mohammed Aldehaim (ORCID: https://orcid.org/0009-0004-6470-3589)
- Saif Aljabab (ORCID: https://orcid.org/0000-0001-7056-3683)
- Hussain AlHussain (ORCID: https://orcid.org/0000-0001-7533-0088)
- Ali Balbaid (ORCID: https://orcid.org/0000-0002-8215-5297)
- Ibraheem Alomary
Institutions
- King Faisal University (SA)
Publication Details
- Journal
- Saudi Medical Journal
- Published
- 2025-11-01
- DOI
- https://doi.org/10.15537/smj.2025.46.11.20250572
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00